In a patient receiving digoxin for SVT, the nurse must consistently monitor the patient for the development of:
a. low uric acid levels.
b. hypercalcemia.
c. hyponatremia.
d. hypokalemia.
Question 2
Mexiletine (Mexitil) is best described as:
a. an oral form of lidocaine used to treat symptomatic ventricular dysrhythmias.
b. a dysrhythmic agent used to prolong the QT interval to space out ectopic beats.
c. an agent used to counter the adverse effects caused by many of the dysrhythmic drugs.
d. a drug used with digoxin to prevent ischemia.